Evidence map›Paper›PMID 11305954›Full record

ArticleBreast cancer research : BCR2001

Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.

K Kittiniyom, K M Gorse, F Dalbegue, J H Lichy, J K Taubenberger, I F Newsham

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  4. Article
  5. Tumor suppressor role of protein 4.1B/DAL-1.Cellular and molecular life sciences : CMLS · 2014
    Review
  6. Article
  7. Aberrant signaling pathways in meningiomas.Journal of neuro-oncology · 2010
    Review
  8. Article
  9. Article
  10. Article
  11. Protein 4.1B suppresses prostate cancer progression and metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Potential Effect of Different Doses of Ionizing Radiation on Genes and Disease.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K KittiniyomDepartment of Pathology, Virginia Commonweath University, Richmond, USA.
K M Gorse
F Dalbegue
J H Lichy
J K Taubenberger
I F Newsham
Armed Forces Institute of Pathology · USVirginia Commonwealth University · US

Funding

MOLECULAR AND CELLULAR ANAYLSIS OF T CELLS DURING DLIK08CA077330 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MARGOLIS, DAVID A · 1998 to 2002
$269k
NCI NIH HHS R29 CA77330
6 · The paper itself

Abstract

We examined the stage specificity and heterogeneity of 18p11 alterations in a series of tumors representing 96 microdissected samples. Significant loss of heterozygosity (LOH) (63%) was found, with 56% occurring early in ductal carcinoma in situ. Although most cases indicated LOH was clonally inherited, heterogeneity for 18p LOH occurred in 27% of tumors. When compared with other LOH data, 18p LOH was found in conjunction with allelic deletion on 3p, 9p, 17p and 17q, while 13q, 16q, and 11p were less frequently associated. These analyses suggest chromosome 18p11 alteration is a common and early event in breast disease.

Indexed as

Loss of HeterozygosityBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma in SituChromosomes, Human, Pair 18Disease ProgressionDNA, NeoplasmDNA, SatelliteFemaleGenetic HeterogeneityGenetic MarkersHumansPolymerase Chain ReactionDNA, NeoplasmDNA, SatelliteGenetic Markers

Identifiers

PMID11305954
PMCPMC30703
OpenAlexW2136396461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.